Abstract
Purpose. To prepare poly(ethyl 2-cyanoacrylate) nanocapsulescontaining insulin by interfacial polymerization of spontaneously forming,biocompatible microemulsions.
Methods. A pseudo-ternary phase diagram of a mixture of mediumchain glycerides (caprylic/capric triglycerides and mono-/diglycerides),a mixture of surfactants (polysorbate 80 and sorbitan mono-oleate) andwater was constructed. Polarizing light microscopy was used to identifycombinations forming microemulsions. Microemulsions werecharacterized by conductivity and viscosity to select systems suitable for thepreparation of poly(ethyl 2-cyanoacrylate) nanocapsules by interfacialpolymerization. Nanocapsules were prepared by addition of 100 mgof ethyl 2-cyanoacrylate to a stirred water-in-oil microemulsioncontaining 1 g of water, 7.6 g of oil, and 1.4 g of surfactant. Thenanocapsules formed were characterized by photon correlation spectroscopy,freeze fracture transmission and scanning electron microscopy. Insulinnanocapsules were prepared by using an aqueous solution of insulin(100 units/ml) as the dispersed phase of the microemulsion. Theentrapment and the release of insulin from the nanocapsules were determined.
Results. Three regions were identified in the pseudo-ternary phasediagram; a microemulsion region, a region in which liquid crystallinestructures were present and a coarse emulsion region. All systems inthe microemulsion region were water-in-oil dispersions.Poly(ethyl 2-cyanoacrylate) nanocapsules having a mean particle size of 150.9 nmwere formed upon interfacial polymerization of the microemulsion.Nanocapsules were found to have a central cavity surrounded by apolymer wall. In excess of 80;pc of the insulin present in themicroemulsion was encapsulated upon interfacial polymerization.
Conclusions. Interfacial polymerization of spontaneously formingwater-in-oil microemulsions represents a convenient method for thepreparation of poly(alkylcyanoacrylate) nanocapsules suitable for theentrapment of bioactive peptides.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
X. H. Zhou and A. L. Wan Po. Peptide and protein drugs: II. Non-parenteral routes of delivery. Int. J. Pharm. 75:117–130 (1991).
V. H. L. Lee, S. Dodda-Kashi, G. M. Grass, and W. Rubas. Oral route of peptide and protein drug delivery. In V. H. L. Lee (ed.) Peptide and Protein Drug Delivery, Marcel Dekker, New York, 1991, pp. 691–738.
P. J. Lowe and C. S. Temple. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: Protection against proteases and effect on intestinal absorption in rats. J. Pharm. Pharmacol. 46:547–552 (1994).
C. Damge, H. Vranckx, P. Balschmidt, and P. Couvreur. Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. J. Pharm. Sci. 86:1403–1409 (1997).
M. Aprahamian, C. Michel, W. Humbert, J. P. Devissaguet, and C. Damge. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell. 61:69–76 (1987).
A. T. Florence, A. M. Hillery, N. Hussain, and P. U. Jani. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J. Control. Rel. 36:39–46 (1995).
C. Damge, C. Michel, M. Aprahamian, and P. Couvreur. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes. 37:246–251 (1988).
M.S. EL-Samaligy, P. Rohdewald, and H. A. Mahmoud. Polyalkylcyanoacrylate nanocapsules. J. Pharm. Pharmacol. 38:216–218 (1986).
H. Vranckx, M. Demoustier, and M. Deleers. A new nanocapsule formulation with hydrophilic core: Application to the oral administration of salmon calcitonin in rats. Eur. J. Pharm. Biopharm. 42:345–347 (1996).
A. Hoffman, H. R. Keiser, E. Grossman, D. S. Goldstein, P. W. Gold, and M. Kling. Oral delivery of insulin. Lancet. 23:1518–1519 (1989).
P. P. Constantinides, G. Welzel, H. Ellens, P. L. Smith, S. Sturgis, S. H. Yiv, and A. B. Owen. Water in oil microemulsions containing medium-chain fatty acids/salts: Formulation and intestinal absorption enhancement evaluation. Pharm. Res. 13:210–215 (1996).
T. Trenktrog, B. W. Muller, and J. Seifert. In vitro-investigation into the enhancement of intestinal peptide absorption by emulsion systems. Eur. J. Pharm. Biopharm. 41:284–290 (1995).
P. P. Constantinides, J. P. Scalart, C. Lancaster, J. Marcello, G. Marks, H. Ellens, and P. L. Smith. Formulation and intestinal absorption enhancement evaluation of water in oil microemulsions incorporating medium chain glycerides. Pharm. Res. 11:1385–1390 (1994).
W. A. Ritschel. Microemulsions for improved peptide absorption from the gastrointestinal tract. Meth. Find. Exp. Clin. Pharmacol. 13:205–220 (1991).
C. J. H. Porter, S. A. Charman, A. J. Humberstone, and W. N. Charman. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: Effect of lipid class and lipid vehicle dispersion. J. Pharm. Sci. 85:357–361 (1996).
D. J. Hauss, S. C. Mehta, and G. W. Radebaugh. Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach. Int. J. Pharm. 108:85–93 (1994).
D. J. Hauss, S. E. Fogal, J. V. Ficorilli, C. A. Price, T. Roy, A. A. Jayaraj, and J. J. Keirns. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 87:164–169 (1998).
J. Kreuter. Nanoparticles, In J. Kreuter (ed.) Drugs and the Pharmaceutical Science, volume 66: Colloidal Drug Delivery Systems, Marcel Dekker, New York, 1994, pp. 219–343.
M. R. Gasco and M. Trotta. Nanoparticles from microemulsions. Int. J. Pharm. 29:267–268 (1986).
E. C. Swenson and W. J. Curatolo. Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev. 8:39–92 (1992).
H. O. Ho, C. C. Hsiao, and M. T. Sheu. Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs. J. Pharm. Sci. 85:138–143 (1996).
S. Muranishi. Absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 7:1–33 (1990).
P. Y. Yeh, P. L. Smith, and H. Ellens. Effect of medium chain glycerides on physiology of intestinal epithelium in vitro. Int. Symp. Control. Rel. Bioact. Mater. 20:176–177 (1993).
C. Damge, C. Michel, M. Aprahamian, P. Couvreur, and J. P. Devissaguet. Nanocapsules as carriers for oral peptide delivery. J. Control. Rel. 13:233–239 (1990).
P. Jani, G. W. Halbert, J. Langridge, and A. T. Florence. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmcol. 41:809–812 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watnasirichaikul, S., Davies, N.M., Rades, T. et al. Preparation of Biodegradable Insulin Nanocapsules from Biocompatible Microemulsions. Pharm Res 17, 684–689 (2000). https://doi.org/10.1023/A:1007574030674
Issue Date:
DOI: https://doi.org/10.1023/A:1007574030674